323 related articles for article (PubMed ID: 33546248)
1. Killing the Invaders: NK Cell Impact in Tumors and Anti-Tumor Therapy.
Molgora M; Cortez VS; Colonna M
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33546248
[TBL] [Abstract][Full Text] [Related]
2. NK Cells and ILC1s in Cancer Biology.
Sliz A; Yokoyama WM
Adv Exp Med Biol; 2022; 1365():41-55. PubMed ID: 35567740
[TBL] [Abstract][Full Text] [Related]
3. Tissue-specific transcriptional profiles and heterogeneity of natural killer cells and group 1 innate lymphoid cells.
Lopes N; Galluso J; Escalière B; Carpentier S; Kerdiles YM; Vivier E
Cell Rep Med; 2022 Nov; 3(11):100812. PubMed ID: 36384102
[TBL] [Abstract][Full Text] [Related]
4. Development, Homeostasis, and Heterogeneity of NK Cells and ILC1.
Seillet C; Belz GT; Huntington ND
Curr Top Microbiol Immunol; 2016; 395():37-61. PubMed ID: 26305047
[TBL] [Abstract][Full Text] [Related]
5. Murine thymic NK cells are distinct from ILC1s and have unique transcription factor requirements.
Gabrielli S; Sun M; Bell A; Zook EC; de Pooter RF; Zamai L; Kee BL
Eur J Immunol; 2017 May; 47(5):800-805. PubMed ID: 28276053
[TBL] [Abstract][Full Text] [Related]
6. Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions.
Mariotti FR; Quatrini L; Munari E; Vacca P; Moretta L
Front Immunol; 2019; 10():910. PubMed ID: 31105707
[TBL] [Abstract][Full Text] [Related]
7.
Park E; Patel S; Wang Q; Andhey P; Zaitsev K; Porter S; Hershey M; Bern M; Plougastel-Douglas B; Collins P; Colonna M; Murphy KM; Oltz E; Artyomov M; Sibley LD; Yokoyama WM
Elife; 2019 Aug; 8():. PubMed ID: 31393266
[TBL] [Abstract][Full Text] [Related]
8. Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies.
Seliger B; Koehl U
Front Immunol; 2022; 13():910595. PubMed ID: 36045670
[TBL] [Abstract][Full Text] [Related]
9. Differential phenotypic and functional properties of liver-resident NK cells and mucosal ILC1s.
Tang L; Peng H; Zhou J; Chen Y; Wei H; Sun R; Yokoyama WM; Tian Z
J Autoimmun; 2016 Feb; 67():29-35. PubMed ID: 26422992
[TBL] [Abstract][Full Text] [Related]
10. Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells.
Kim N; Kim HS
Front Immunol; 2018; 9():2041. PubMed ID: 30250471
[TBL] [Abstract][Full Text] [Related]
11. Natural killers or ILC1s? That is the question.
Seillet C; Brossay L; Vivier E
Curr Opin Immunol; 2021 Feb; 68():48-53. PubMed ID: 33069142
[TBL] [Abstract][Full Text] [Related]
12. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
[TBL] [Abstract][Full Text] [Related]
13. The Central Nervous System Contains ILC1s That Differ From NK Cells in the Response to Inflammation.
Romero-Suárez S; Del Rio Serrato A; Bueno RJ; Brunotte-Strecker D; Stehle C; Figueiredo CA; Hertwig L; Dunay IR; Romagnani C; Infante-Duarte C
Front Immunol; 2019; 10():2337. PubMed ID: 31649664
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cells as a promising therapeutic target for cancer immunotherapy.
Kim N; Lee HH; Lee HJ; Choi WS; Lee J; Kim HS
Arch Pharm Res; 2019 Jul; 42(7):591-606. PubMed ID: 30895524
[TBL] [Abstract][Full Text] [Related]
15. PLZF expression maps the early stages of ILC1 lineage development.
Constantinides MG; Gudjonson H; McDonald BD; Ishizuka IE; Verhoef PA; Dinner AR; Bendelac A
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5123-8. PubMed ID: 25838284
[TBL] [Abstract][Full Text] [Related]
16. Type 1 Innate Lymphoid Cell Biology: Lessons Learnt from Natural Killer Cells.
Jiao Y; Huntington ND; Belz GT; Seillet C
Front Immunol; 2016; 7():426. PubMed ID: 27785129
[TBL] [Abstract][Full Text] [Related]
17. Role of NK Cells in Tumor Progression.
Terrén I; Borrego F
Exp Suppl; 2022; 113():169-187. PubMed ID: 35165864
[TBL] [Abstract][Full Text] [Related]
18. Markers and function of human NK cells in normal and pathological conditions.
Del Zotto G; Marcenaro E; Vacca P; Sivori S; Pende D; Della Chiesa M; Moretta F; Ingegnere T; Mingari MC; Moretta A; Moretta L
Cytometry B Clin Cytom; 2017 Mar; 92(2):100-114. PubMed ID: 28054442
[TBL] [Abstract][Full Text] [Related]
19. NK cells to cure cancer.
Di Vito C; Mikulak J; Zaghi E; Pesce S; Marcenaro E; Mavilio D
Semin Immunol; 2019 Feb; 41():101272. PubMed ID: 31085114
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential and challenges of natural killer cells in treatment of solid tumors.
Gras Navarro A; Björklund AT; Chekenya M
Front Immunol; 2015; 6():202. PubMed ID: 25972872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
